LOGC moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend. In of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where LOGC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for LOGC turned negative on January 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LOGC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on LOGC as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 10-day moving average for LOGC crossed bullishly above the 50-day moving average on January 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LOGC advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LOGC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.180) is normal, around the industry mean (4.602). P/E Ratio (0.000) is within average values for comparable stocks, (60.338). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.682). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (1.800) is also within normal values, averaging (5.577).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LOGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
a developer of viral vectors for the treatment of genetic diseases
Industry InternetRetail
A.I.dvisor indicates that over the last year, LOGC has been closely correlated with EPIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if LOGC jumps, then EPIX could also see price increases.
Ticker / NAME | Correlation To LOGC | 1D Price Change % | ||
---|---|---|---|---|
LOGC | 100% | +1.93% | ||
EPIX - LOGC | 67% Closely correlated | N/A | ||
TSHA - LOGC | 45% Loosely correlated | -3.16% | ||
PCVX - LOGC | 45% Loosely correlated | -2.88% | ||
ATNM - LOGC | 43% Loosely correlated | +14.75% | ||
LGND - LOGC | 39% Loosely correlated | +0.73% | ||
More |
Ticker / NAME | Correlation To LOGC | 1D Price Change % |
---|---|---|
LOGC | 100% | +1.93% |
Retail Trade category (412 stocks) | 22% Poorly correlated | +0.53% |
treatment category (55 stocks) | 19% Poorly correlated | +0.11% |
diseases category (42 stocks) | 16% Poorly correlated | +1.16% |
pharmaceuticals category (161 stocks) | 15% Poorly correlated | +0.20% |
Internet Retail category (90 stocks) | 10% Poorly correlated | +1.06% |